Industry Verticals »

All Categories

Insights »

About TMR »

Immunoassay Instruments Market

Immunoassay Instruments Market (Product Chemiluminescence (CLI), Immunofluorescence (IFA) & Radioimmunoassay (RIA) Analyzers, Enzyme Linked Fluorescence (ELFA) & Multiplexed Assay Systems, Enzyme Immunoassay Instruments Application Oncology, Endocrinology, Infectious Diseases, Therapeutic Drug Monitoring, Cardiology, Autoimmune Disorders & Drugs of Abuse) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Immunoassay instruments market is witnessing a rapid technological growth that has resulted in significant market opportunity for efficient bioanalytical platforms. Currently, market players are engaged in developing immunoassay platforms with enhanced capabilities such as broad menu of tests, higher sensitivity and specificity. Other major advances introduced to researchers include shorter turnaround times (TAT), higher productivity and easy operation thereby ensuring efficient detection and determination with accurate results. The market is witnessing significant advances in the design of immunoassay platforms shifting from conventional non-competitive assays to competitive assays that are permitting the efficient detection of small molecules such as drug pollutants and metabolites. For instance, introduction of ADVIA Centaur CP Immunoassay System by Siemens Healthcare, a mid-sized immunoassay system that provides a broad menu of tests and enhanced workflow which enables overall cost reduction and eliminate the need for multiple systems. 
 
Although, the use of immunoassay platforms has been confined to hospitals and reference laboratories, currently, there is an increasing preference for commercial diagnostic laboratories owing to their special care and short turnaround times as compared to hospitals. Tier-1 diagnostic laboratories are currently focusing on expanding their operations in less developed areas by acquiring Tier - 2 and Tier – 3 laboratories with minimal infrastructure. This creates a strong demand for compact and portable assay platforms with high reliability and sensitivity. In addition, these platforms can run on batteries in case of power failure and can be moved in ambulances in case of emergency requirements. All these features along with high affordability are expected to provide impressive growth opportunities for immunoassay instruments market.
 
Chemiluminescence analyzers are the fastest growing segment owing to their high sensitivity and accuracy as compared to other assay platforms. Immunofluorescence analyzers and ELFA systems constitute other major instrument segments that provide high reliability and accuracy in detection. The use of radioimmunoassay analyzers is diminishing owing to the harmful effects of radioisotopes used in the assays. The market for immunoassay instruments is influenced by consistent product modifications such as use of efficient assay substrates, and low cost light sources. 
 
Immunoassays aid in the detection of several analytes and diagnosis of several infectious diseases. Growing preference for personalized medicine (a medical model focusing on development of patient specific therapeutics), will further enhance the scope of growth and development of immunoassay platforms. Endocrinology, cardiology, detection of autoimmune disorders and infectious disease confirmation represent other potential applications of immunoassay platforms. The global market for immunoassay instruments market was valued at USD 13.51 billion in the year 2013 and is anticipated to reach USD 23.31 billion by 2020, growing at a CAGR of 8.1% from 2014 to 2020.
 
Geographical landscape elucidates the market trends based on four major geographies namely North America, Europe, Asia-Pacific and Rest of the World (RoW). North America and Europe dominated the immunoassay instruments market accounting for more than 50% of the total market. This is majorly attributed to the presence of technologically sophisticated diagnostic laboratories along with ready acceptance of novel assay technologies. In addition, these regions are characterized by the presence of major market players operating in immunoassay instruments market. Asia-Pacific and RoW regions are anticipated to record highest growth rates owing to increasing demand for immunoassay platforms and rising incidences of several disorders (infectious, endocrine, etc.). In addition, these regions provide lucrative growth prospects due to huge patient population and unexplored areas of medical research as compared to North America and European countries that indicate a mature market for immunoassay instruments. 
 
The overall immunoassay instruments market is consolidated characterized by the presence of few established players accounting for more than 50% of the total market share. Roche Diagnostics, Siemens Healthcare, Beckman Coulter, bioMerieux and Ortho Clinical Diagnostics are some of the key players operating in this market. Rigorous research investments coupled with operational expansion in emerging economies by majority of the market players are evident for promising growth prospects in this market. The factors that influence the proliferation of market are perennial product amendments followed by increasing patient population worldwide. On the other hand, high cost of the immunoassay procedures followed by unfavorable reimbursement policies might impede the market growth.
     
    Chapter 1 Introduction
    1.1 Report Description
    1.2 Research Methodology
          1.2.1 Sources
                  1.2.1.1 Secondary Research
                  1.2.1.2 Primary Research
                  1.2.1.3 Assumptions
    1.3 Market Segmentation
    1.4 List of Abbreviations
     
    Chapter 2 Executive Summary
    2.1 Comparative Analysis: Global Immunoassay Instruments Market, by Geography, 2013 & 2020 (Value %)
     
    Chapter 3 Market Overview
    3.1 Introduction
          3.1.1 Flow Chart of Immunoassay Development, Optimization and Validation
    3.2 Market Potential of Immunoassay Instruments
          3.2.1 Biomarker Discovery Process
    3.3 Future Scenario of Immunoassay Instruments Market
    3.4 Event Impact Analysis
    3.5 Market Dynamics
    3.6 Market Drivers
          3.6.1 Rising incidence of chronic infectious diseases will drive the immunoassay instruments market
          3.6.2 Rate of HIV Infections by World Regions, (2001-2012)
          3.6.3 Technological advances coupled with enhanced discovery of specific biomarkers will drive the demand for immunoassay instruments
          3.6.4 Increasing preference for personalized medicine creates a demand for novel and specific immunoassays
    3.7 Market Restraints
          3.7.1 High cost associated with technologically advanced immunoassay systems
    3.8 Market Opportunities
          3.8.1 Focus on developing compact, portable reliable immunoassay instruments
          3.8.2 Investments in emerging economies
    3.9 Value Chain Analysis: Global Immunoassay Instruments Market
    3.10 Regulatory and Reimbursement Overview
    3.11 Porter’s Five Forces Analysis for the Global Immunoassay Instruments Market
          3.11.1 Bargaining power of suppliers
          3.11.2 Bargaining power of buyers
          3.11.3 Threat of substitutes
          3.11.4 Threat of new entrants
          3.11.5 Competitive rivalry
    3.12 Market Attractiveness Analysis: Global Immunoassay Instruments Market, by Geography
    3.13 Comparative Analysis: Global Immunoassay Instruments Market, by End Users, 2013 & 2020 (Value %)
    3.14 Competitive Landscape
          3.14.1 Global Immunoassay Instruments Market Share by Key Players, 2013 (Value %)
     
    Chapter 4 Global Immunoassay Instruments Market, by Products
    4.1 Overview
          4.1.1 Global Immunoassay Instruments Market Revenue, by Products, 2012 - 2020 (USD Billion)
    4.2 Comparative Analysis: Global Immunoassay Instruments Market, by Products, 2013 & 2020 (Value %)
    4.3 Chemiluminescence (CLI) Analyzers
          4.3.1 Global Chemiluminescence (CLI) Analyzers Market Revenue, 2012- 2020 (USD Billion)
    4.4 Immunofluorescence Analyzers (IFA)
          4.4.1 Global Immunofluorescence Analyzers Market Revenue, 2012- 2020 (USD Billion)
    4.5 Enzyme Immunoassay Instruments
          4.5.1 Global Enzyme Immunoassay (EIA) Instruments Market Revenue, 2012 - 2020 (USD Billion)
    4.6 Radioimmunoassay (RIA) Instruments
          4.6.1 Global Radioimmunoassay (RIA) Instruments Market Revenue, 2012 – 2020 (USD Billion)
    4.7 Enzyme Linked Fluorescent Assay (ELFA) Systems
          4.7.1 Global Enzyme Linked Fluorescent Assays (ELFA) Instruments Market Revenue, 2012 – 2020 (USD Billion)
    4.8 Multiplexed Assay Systems
          4.8.1 Global Multiplexed Assay Systems Market Revenue, 2012 – 2020 (USD Billion)
     
    Chapter 5 Global Immunoassay Instruments Market, by Application
    5.1 Overview
          5.1.1 Global Immunoassay Instruments Market Revenue, by Application, 2012 – 2020 (USD Billion)
    5.2 Comparative Analysis: Global Immunoassay Instruments Market, by Application, 2012 – 2020 (Value %)
    5.3 Endocrinology
          5.3.1 Global Endocrinology Application Market Revenue, 2012- 2020 (USD Billion)
    5.4 Infectious Disease Testing
          5.4.1 Global Infectious Disease Testing Application Market Revenue, 2012- 2020 (USD Billion)
    5.5 Oncology
          5.5.1 Global Oncology Application Market Revenue, 2012- 2020 (USD Billion)
    5.6 Cardiology
          5.6.1 Global Cardiology Application Market Revenue, 2012- 2020 (USD Billion)
    5.7 Therapeutic Drug Monitoring
          5.7.1 Global Therapeutic Drug Monitoring Application Market Revenue, 2012- 2020 (USD Billion)
    5.8 Autoimmune Diseases Testing
          5.8.1 Global Autoimmune Diseases Testing Application Market Revenue, 2012- 2020 (USD Billion)
    5.9 Drugs of Abuse Testing
          5.9.1 Global Drug Abuse Testing Application Market Revenue, 2012- 2020 (USD Billion)
     
    Chapter 6 Global Immunoassay Instruments Market, by Geography
    6.1 Overview
          6.1.1 Global Immunoassay Instruments Market Revenue, by Geography, 2012 – 2020 (USD Billion)
    6.2 North America
          6.2.1 North America Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
    6.3 Europe
          6.3.1 Europe Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
    6.4 Asia-Pacific
          6.4.1 Asia-Pacific Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
    6.5 Rest of the World (RoW)
          6.5.1 RoW Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)
     
    Chapter 7 Recommendations
    7.1 Recommendations
          7.1.1 Enhancing distribution networks
          7.1.2 Improvements in after sale services to hospitals, diagnostic labs and private practitioners
          7.1.3 Expansion in emerging regions such as Asia and Africa
     
    Chapter 8 Company Profiles
    8.1 Abbott Laboratories
          8.1.1 Company Overview
          8.1.2 Financial Overview
          8.1.3 Product Portfolio
          8.1.4 Business Strategies
          8.1.5 Recent Developments
    8.2 Beckman Coulter, Inc.
          8.2.1 Company Overview
          8.2.2 Financial Overview
          8.2.3 Product Portfolio
          8.2.4 Business Strategies
          8.2.5 Recent Developments
    8.3 bioMerieux, Inc.
          8.3.1 Company Overview
          8.3.2 Financial Overview
          8.3.3 Product Portfolio
          8.3.4 Business Strategies
          8.3.5 Recent Developments
    8.4 DiaSorin S.p.A
          8.4.1 Company Overview
          8.4.2 Financial Overview
          8.4.3 Product Portfolio
          8.4.4 Business Strategies
          8.4.5 Recent Developments
    8.5 F. Hoffman-La Roche, Ltd.
          8.5.1 Company Overview
          8.5.2 Financial Overview
          8.5.3 Product Portfolio
          8.5.4 Business Strategies
          8.5.5 Recent Developments
    8.6 Merck Millipore
          8.6.1 Company Overview
          8.6.2 Financial Overview
          8.6.3 Product Portfolio
          8.6.4 Business Strategies
          8.6.5 Recent Developments
    8.7 Ortho Clinical Diagnostics
          8.7.1 Company Overview
          8.7.2 Financial Overview
          8.7.3 Product Portfolio
          8.7.4 Business Strategies
          8.7.5 Recent Developments
    8.8 Siemens Healthcare
          8.8.1 Company Overview
          8.8.2 Financial Overview
          8.8.3 Product Portfolio
          8.8.4 Business Strategies
          8.8.5 Recent Developments
    8.9 Sysmex Corporation
          8.9.1 Company Overview
          8.9.2 Financial Overview
          8.9.3 Product Portfolio
          8.9.4 Business Strategies
          8.9.5 Recent Developments
    8.10 Thermo Fisher Scientific
           8.10.1 Company Overview
           8.10.2 Financial Overview
           8.10.3 Product Portfolio
           8.10.4 Business Strategies
           8.10.5 Recent Developments
    List of Tables
     
    TABLE 1 List of Abbreviations
    TABLE 2 Market Snapshot: Global Immunoassay Instruments Market
    TABLE 3 Event Impact Analysis, 2012 – 2020
    TABLE 4 Global Immunoassay Instruments Market Revenue, by Products, 2012 – 2020 (USD Billion)
    TABLE 5 Global Immunoassay Instruments Market Revenue, by Application, 2012 – 2020 (USD Billion)
    TABLE 6 Global Immunoassay Instruments Market Revenue, by Geography, 2012 – 2020 (USD Billion)

    List of Figures

     

    FIG. 1 Immunoassay Instruments Market Segmentation

    FIG. 2 Global Immunoassay Instruments Market, by Applications, 2013 (USD Billion)

    FIG. 3 Global Immunoassay Instruments Market, by Products, 2013 (USD Billion)

    FIG. 4 Comparative Analysis: Global Electrodes for Medical Devices Market, by Geography, 2013 & 2020 (Value %)

    FIG. 5 Immunoassay Development, Optimization and Validation Process

    FIG. 6 Biomarker Discovery Process

    FIG. 7 Rate of HIV Infections by World Regions, (2001 – 2012)

    FIG. 8 Global Immunoassay Instruments Market Value Chain Analysis

    FIG. 9 Porter’s Five Forces Analysis: Global Immunoassay Instruments Market

    FIG. 10 Market Attractiveness Analysis: Global Immunoassay Instruments Market, by Geography, 2013

    FIG. 11 Comparative Analysis: Global Immunoassay Instruments Market, by End Users, 2013 & 2020 (Value %)

    FIG. 12 Immunoassay Instruments: Global Market Share by Key Players, 2013 (Value %)

    FIG. 13 Comparative Analysis: Global Immunoassay Instruments Market, by Products, 2013 & 2020 (Value %)

    FIG. 14 Global Chemiluminescence (CLI) Analyzers Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 15 Global Immunofluorescence Analyzers Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 16 Global Enzyme Immunoassay (EIA) Instruments Market Revenue, 2012 - 2020 (USD Billion)

    FIG. 17 Global Radioimmunoassay (RIA) Instruments Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 18 Global ELFA Instruments Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 19 Global Multiplexed Assay Systems Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 20 Comparative Analysis: Global Immunoassay Instruments Market, by Application, 2013 & 2020 (Value %)

    FIG. 21 Global Endocrinology Application Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 22 Global Infectious Disease Testing Application Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 23 Global Oncology Application Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 24 Global Cardiology Application Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 25 Global Therapeutic Drug Monitoring Application Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 26 Global Autoimmune Diseases Testing Application Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 27 Global Drug Abuse Testing Application Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 28 North America Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 29 Europe Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 30 Asia-Pacific Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 31 RoW Immunoassay Instruments Market Revenue, 2012 – 2020 (USD Billion)

    FIG. 32 Abbott Laboratories, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 33 bioMerieux, Inc.: Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 34 DiaSorin, Annual Revenue: 2011 – 2013 (USD Million)

    FIG. 35 F. Hoffman-La Roche, Ltd.: Annual Revenue (Group Sales), 2011 – 2013 (USD Million)

    FIG. 36 Merck Millipore, Annual Revenue, 2010 – 2012 (USD million)

    FIG. 37 Ortho Clinical Diagnostics, Annual Revenue: 2011 – 2013 (USD Million)

    FIG. 38 Siemens Healthcare, Annual Revenue (Group Revenue): 2011– 2013 (USD Million)

    FIG. 39 Sysmex Corporation, Annual Revenue, 2011 – 2013 (USD Million)

    FIG. 40 Thermo Fisher Scientific, Annual Revenue: 2011 – 2013 (USD million)

Copyright © Transparency Market Research, Inc. All Rights reserved

Immunoassay Instruments Market

Schedule a Call